AstraZeneca to Buy TeneoTwo for Up to $1.27 Billion
05 Julio 2022 - 1:46AM
Noticias Dow Jones
By Ian Walker
AstraZeneca PLC said Tuesday that it is buying TeneoTwo, Inc.
for up to $1.27 billion in a deal that strengthens its
haematological cancer pipeline.
The pharmaceutical giant said it will make an upfront payment of
$100 million upon closing of the deal. A further payment of up to
$805 million will be made dependent upon research-and-development
milestones being reached and extra payments of up to $360 million
could be payable to TeneoTwo shareholders based upon
commercial-related milestones.
Astra said the acquisition is expected to close in the third
quarter of this year and that it doesn't impact financial guidance
for the year.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
July 05, 2022 02:31 ET (06:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Astrazeneca (LSE:AZN)
Gráfica de Acción Histórica
De May 2023 a May 2024
